Roche

Genentech and Kronos Bio announce oncology partnership worth over $570m

Genentech – a member of the Roche group – and Kronos Bio (Kronos) have entered into a discovery collaboration to advance novel therapies for transcriptional targets in oncology. ... James Sabry, global head of Roche Pharma Partnering, said: “We are

Roche’s COVID-19 antibody receives FDA approval for hospitalised adults

Roche’s Actemra (tocilizumab) has been approved by the US Food and Drug Administration (FDA) for the treatment of COVID-19 in hospitalised adults, the company announced.

Biogen and Genentech sign royalty agreement for blood cancer drug glofitamab

Biogen has reached an agreement with Genentech – a member of the Roche group – on the potential commercialisation of the investigational bispecific antibody, glofitamab, as part of the companies’ long-standing collaboration

Creative destruction

Recently, a statement from Roche resonated strongly with my study of the pharmaceutical innovation ecosystem. ... Roche and other companies are very good at seeing which way this wind is blowing.

Novartis partners with Cancer Research UK for rare cancer trial

The study was launched by Cancer Research UK’s Centre for Drug Development, the University of Manchester and Roche. ... With Novartis on board, Roche will continue providing access to cancer treatments via the study, supported by sponsorship and

[ Previous 5 results ] 6 7 8 9 10 11 12 13 14 15 [ Next 5 results ]